- Home
- CHNR vs TRIB Comparison
CHNR vs TRIB Comparison
Compare CHNR & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- TRIB
- Stock Information
- Founded
- CHNR N/A
- TRIB 1992
- Country
- CHNR China
- TRIB Ireland
- Employees
- CHNR N/A
- TRIB N/A
- Industry
- CHNR Precious Metals
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CHNR Basic Materials
- TRIB Health Care
- Exchange
- CHNR Nasdaq
- TRIB Nasdaq
- Market Cap
- CHNR 5.3M
- TRIB 5.4M
- IPO Year
- CHNR 1995
- TRIB N/A
- Fundamental
- Price
- CHNR $5.57
- TRIB $1.00
- Analyst Decision
- CHNR
- TRIB
- Analyst Count
- CHNR 0
- TRIB 0
- Target Price
- CHNR N/A
- TRIB N/A
- AVG Volume (30 Days)
- CHNR 991.2K
- TRIB 120.8K
- Earning Date
- CHNR 12-12-2025
- TRIB 11-14-2025
- Dividend Yield
- CHNR N/A
- TRIB N/A
- EPS Growth
- CHNR N/A
- TRIB N/A
- EPS
- CHNR N/A
- TRIB N/A
- Revenue
- CHNR N/A
- TRIB $61,555,000.00
- Revenue This Year
- CHNR N/A
- TRIB $13.51
- Revenue Next Year
- CHNR N/A
- TRIB $13.14
- P/E Ratio
- CHNR N/A
- TRIB N/A
- Revenue Growth
- CHNR N/A
- TRIB 8.31
- 52 Week Low
- CHNR $3.16
- TRIB $0.48
- 52 Week High
- CHNR $8.20
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- CHNR 48.97
- TRIB 44.66
- Support Level
- CHNR $5.77
- TRIB $0.88
- Resistance Level
- CHNR $6.43
- TRIB $1.10
- Average True Range (ATR)
- CHNR 0.81
- TRIB 0.07
- MACD
- CHNR -0.10
- TRIB 0.00
- Stochastic Oscillator
- CHNR 17.81
- TRIB 42.51
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.